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Acute myocardial infarction (MI) is a serious complication 
after total hip and knee arthroplasty (THA/TKA). Despite 
improvements in perioperative optimization and enhanced 
recovery throughout the last decades (Kehlet 2013), MI 
remains one of the most frequent causes of mortality follow-
ing THA and TKA (Malviya et al. 2011, Kirksey et al. 2012, 
Bemenderfer et al. 2017, Jørgensen et al. 2017). Recent stud-
ies investigating the occurrence of postoperative MI found 
varying incidences both in hospital (0.2%–0.7%) (Menen-
dez et al. 2015, Bemenderfer et al. 2017, Urban et al. 2017), 
after 30 days (0.3%–0.9%) (Singh et al. 2011, Belmont Jr et 
al. 2014, Pedersen et al. 2014, Thornqvist et al. 2014), and 
after 6 weeks (0.5% for THA and 0.2% for TKA) (Lalmo-
hamed et al. 2012). In contrast, a recent large observational 
study on fast-track THA and TKA has shown a low 0.2% inci-
dence of MI (Jørgensen et al. 2016b) and another observa-
tional study found a marked decrease in 30-day incidence of 
MI from around 0.9% before to 0.4% after implementation of 
a fast-track protocol (Khan et al. 2014). Furthermore, a recent 
study on early thromboembolic events after fast-track THA 
and TKA reported an incidence of only 0.07% for MI either 
in hospital or within the first postoperative week, with a minor 
increase to 0.10% within 30 days of surgery (Jørgensen et al. 
2016a). However, most of the established evidence on inci-
dence and risk factors for MI following THA and TKA derive 
from administrative databases relying on diagnostic codes or 
insurance data (Kirksey et al. 2012, Lalmohamed et al. 2012, 
Belmont Jr et al. 2014, Thornqvist et al. 2014, Menendez et 
al. 2015, Bemenderfer et al. 2017, Urban et al. 2017). These 
databases lack detailed information on perioperative care, 
which limits the ability to identify potential pathophysiologi-
cal events leading to MI. Additionally, a novel comparison of 
Background and purpose — Acute myocardial infarc-
tion (MI) is a leading cause of mortality following total hip 
and knee arthroplasty (THA/TKA). The reported 30-day 
incidence of MI varies from 0.3% to 0.9%. However, most 
data derive from administration and insurance databases or 
large RCTs with potential confounding factors. We studied 
the incidence of and potential modifiable risk factors for 
postoperative MI in a large, multicenter optimized “fast-
track” THA/TKA setting.
Patients and methods — A prospective cohort study 
was conducted on consecutive unselected elective primary 
unilateral THA and TKA, using prospective information 
on comorbidities and complete 90-day follow-up from the 
Danish National Patient Registry. Evaluation of discharge 
summaries and medical records was undertaken in cases of 
suspected MI. Logistic regression analyses were carried out 
for identification of preoperative risk factors.
Results — Of 24,862 procedures with a median length 
of stay 2 (IQR 2–3) days, 30- and 90-day incidence of MI 
was 31 (0.12%) and 48 (0.19%). Preoperative risk factors 
for MI ≤ 30 days were age > 85 years (OR 7.4, 95% CI 2.3–
24), insulin-dependent diabetes mellitus (IDDM) (3.6, CI 
1.1–12), cardiovascular disease (2.4, CI 1.1–5.0) and hyper-
cholesterolemia (2.3, CI 1.1–5.1). Of 31 patients with MI ≤ 
30 days 9 were treated with vasopressors for intraoperative 
hypotension and 27 had postoperative anemia.
Interpretation — Fast-track THA and TKA had a low 
30-day MI incidence. Focus on patients with age > 85, 
IDDM, cardiovascular disease, and hypercholesterolemia 
may further reduce the 30-day incidence of MI. The role 
of postoperative anemia and intraoperative hypotension are 
other areas for further improvement
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NSQIP data and administrative databases has shown a low 
specificity of around 81% for both, and with chart review of 
a single complication as the “gold standard” (Etzioni et al. 
2018). Consequently, we present results from a large prospec-
tive multicenter database on consecutive unselected elective 
primary THA and TKA in established fast-track settings with 
complete 90-day follow-up and chart review (Jørgensen and 
Kehlet 2013). We investigated the incidence of postoperative 
MI, potential modifiable preoperative risk factors, periopera-
tive events disposing to the occurrence of MI, and MI related 
mortality after fast-track THA and TKA. 
Patients and methods
This was an observational cohort study on prospectively collected 
consecutive unselected primary THA and TKA patients between 
January 2010 and October 2015. All patients were treated at 
8 Danish orthopedic centers (> 200 procedures per year) with 
established fast-track protocols and reporting to the Lundbeck 
Foundation Centre for Fast-track Hip and Knee Replacement 
database (LCDB) (Jørgensen and Kehlet 2013). The fast-track 
setup included regional anesthesia, multimodal opioid-sparing 
analgesia, in-hospital thromboprophylaxis, and early mobiliza-
tion with discharge to own home (> 95%) when fulfilling a set of 
functional discharge criteria (Jørgensen et al. 2013).
Data on preoperative comorbidity and patient demograph-
ics were prospectively collected by patient reported question-
naires. Length of stay (LOS) (postoperative nights in hospital, 
including transfer to other departments and hospitals), 90-day 
readmission (≥ 1 night in hospital, and potentially surgically 
related) and mortality (Jørgensen and Kehlet 2013) were 
obtained from the Danish National Patient Registry (DNPR) 
(Schmidt et al. 2015). In case of LOS ≥ 5 days, readmission, 
or death within 90 days discharge summaries were analyzed. 
Furthermore, in all cases of suspected MI in the discharge sum-
mary or a diagnostic code (ICD10) related to MI in the DNPR, 
the complete medical records were reviewed. MI was classi-
fied according to the proposed EPCO definitions (Jammer et 
al. 2015). Additionally, in cases with MI ≤ 30 days results 
from blood samples and intraoperative anesthesia notes were 
acquired in order to identify any potential association between 
intraoperative events, anemia, and postoperative MI. Pre- and 
postoperative anemia were defined as hemoglobin (HB) < 
13 g/dL for both male and females (Muñoz et al. 2017) and 
intraoperative hypotension was defined as an intraoperative 
systolic blood pressure < 90 mmHg classified as dichotomous 
outcome (Sessler et al. 2017). Furthermore, in case of death 
the complete medical records on primary admission and even-
tual readmissions were obtained to establish cause of death 
and potential relation to index surgery. Finally, we obtained 
and analyzed discharge papers of patients with new postop-
erative administrations of anticoagulants through the Danish 
National Database of Reimbursed Prescriptions (Johannesdot-
tir et al. 2012), to establish indication for the prescription. All 
discharge papers and medical records were initially analyzed 
by either the first (PBP) (patients from October 2013–Novem-
ber 2015) or the senior author (CCJ) (January 2010–Septem-
ber 2013). In cases of doubt the papers were evaluated by all 
authors until agreement was reached. 
Outcomes
Primary outcome was 30-day incidence of MI. Secondarily 
we investigated 90-day incidence, time course, and risk fac-
tors for MI.
Statistics
No pre-study power analysis was conducted as we included 
all available procedures from the LCDB. Continuous data 
are presented as means (SD) or medians (IQR) and analyzed 
using Student’s t-test and non-parametric testing as appropri-
ate. Categorical data are presented as actual number ((%) if 
n > 100, 95% confidence interval (CI)), and tested using χ2 
or Fisher’s-exact test. We calculated risk factors with CI by 
multivariable logistic regression analyses in 4 models for MI 
≤ 30 days and 4 similar models for MI ≤ 90 days. Variable 
selection was done based on clinically acknowledged risk fac-
tors (Mantilla et al. 2011, Belmont Jr et al. 2014) and directed 
acyclic graphs to reduce possible bias (Shrier and Platt 2008).
Due to the risk of mediation between cardiac disease, anti-
coagulant treatment, and hypercholesterolemia and between 
anticoagulant treatment, anemia, and cardiac disease, we con-
structed 4 models. The 1st included age (grouped in 5-year 
intervals), sex, diabetes, cardiovascular disease, and anemia. 
The 2nd included anticoagulant treatment but excluded car-
diovascular disease and anemia. The 3rd included age, sex, 
diabetes, and hypercholesterolemia and the 4th included age, 
sex, diabetes, hypercholesterolemia, and cardiovascular dis-
ease. All variables were included as direct effects. Further-
more, to check for potential bias by including patients with 
more than 1 procedure (Bryant et al. 2006, Ravi et al. 2013) we 
performed a sensitivity analysis by analyzing incidence and 
risk factors from multiple logistic regression model 4 among 
the independent observations (patients with only 1 procedure). 
Statistical significance was defined as p < 0.05. All analyses 
were carried out using SPSS v.22 (IBM Corp, Armonk, NY, 
USA) and http://vassarstats.net/prop1.html for calculation of 
CI for proportions. 
Ethics, registration, funding, and potential conflicts of 
interest
No ethical approval was necessary due to the non-interven-
tional study design. Permission to store and review patient data 
without prior informed consent was obtained from the Danish 
Data protection Agency (RH-2017-132) and the Danish 
National Board of Health (3-3013-56/2/EMJO). Furthermore, 
LCDB is registered on ClinicalTrials.gov (ID: NCT01515670) 
as an ongoing study registry for this type of studies.
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The study was supported by a PhD grant to PBP from Lund-
beckfonden (R230-2017-166), which took no part in organiz-
ing, analyzing, or writing the manuscript.  Outside the submit-
ted work HK is a member of the advisory board at “Rapid 
Recovery” by Zimmer Biomet and CCJ received speakers’ 
fees from “Rapid Recovery” by Zimmer Biomet.
Results
We included 24,862 procedures in 22,291 patients (97% of 
performed procedures) (Figure 1). Mean age was 68 (11) 
years and 58% were females (Table 1). Median LOS was 2 
(2–3) days and 7.3% (CI 7.0–7.6) had a LOS ≥ 5 days. 30- and 
90-day readmission rates were 5.6% (CI 5.3–5.8) and 7.6% 
(CI 7.3–7.9), respectively. Overall mortality was 0.15% (CI 
0.11–0.21) within 30 days and 0.31% (0.25–0.39) within 90 
days. 
The 30-day incidence of MI was 31 (0.12%, CI 0.08–0.17) 
and time to MI was median 4 (2–8) days after surgery, with 
13 (0.05%, CI 0.03–0.09) during primary admission. Of the 
MIs, 6 were diagnosed by rise in troponin combined with ECG 
abnormalities and 7 by troponin and symptoms of ischemia. In 
the remaining 18 patients, 5 MIs were verified by coronary 
angiography, 12 by percutaneous coronary intervention, and 
1 by radiological evidence of new loss of viable myocardium.
In addition, 17 (0.07%, CI 0.04–0.11) MIs occurred during 
days 30–90 resulting in a 90-day incidence of 48 (0.19%, CI 
0.14–0.25) (Figure 2), similar between THA (n = 29, 0.22%, 
CI 0.15–0.32) and TKA (n = 19, 0.16%, CI 0.10–0.25) (p = 
0.3). Median time to MI was 11 (3–56) days for MI ≤ 90 days. 
Prior to readmission with MI 1 patient had a readmission due 
to anemia 2 days prior to admission with MI (8 days post-
operatively, LOS 1). No additional readmissions prior to MI 
occurred in the 47 remaining patients.
90-day mortality was 77 (0.31%, CI 0.25–0.39), of which 
proven or suspected MI was the primary cause of death in 5 
(0.02%) patients. Of the 5 deaths caused by proven or sus-
pected MI, 3 occurred during primary admission (postopera-
tive days 2, 3, and 4) and 2 were after discharge (days 15 and 
43). The 90-day mortality rate for postoperative MI patients 
Total number of  THA and TKA in DNPR 
between January 2010 and October 2015
n = 28,150
Excluded (n = 3,288):
– fractures, non-elective procedures or previous 
   surgery on the same joint within 90 days, 1,615
– severe congenital disordes, infection or cancer, 134
– simultaneous or staged bilateral procedures within 
   90 days, 647
– other (e.g. non-Danish citizens and no standard fast 
   track procedure, 34
– procedures not in the Lundbeck Centre Database, 858
Primary elective unilateral THA/TKA with
completed preoperative questionnaire
n = 24,862
Table 1. Preoperative patient characteristics. Values are 
number (%) unless otherwise stated
 TKA THA
Characteristic 11,873  (47.8) 12,989  (52.2)
Age a (years) 68 (10) 68 (11)
 < 50 559 (4.7) 857 (6.6)
 50–60 2,135 (18) 1,926 (15)
 61–65 1,790 (15) 1,808 (14)
 66–70 2,374 (20) 2,669 (21)
 71–75 2,279 (19) 2,378 (18)
 76–80 1,641 (14) 1,874 (14)
 81–85 818 (6.9) 1,025 (7.9)
 > 85 277 (2.3) 452 (3.5)
Female sex 7,236 (61) 7,221 (56)
BMI        
 < 18.5 44 (0.4) 132 (1.0)
 18.5–24.9 2,305 (19) 4,411 (34)
 25.0–29.9 4,528 (38) 5,309 (41)
 30.0–34.9 3,118 (26) 2,335 (18)
 35.0–39.9 1,298 (11) 549 (4.2)
 ≥ 40 524 (4.4) 172 (1.3)
 Missing 56 (0.5) 81 (0.6)
Smoking 1,542 (13) 1,955 (15)
 Missing 86 (0.7) 87 (0.7)
Alcohol > 2 units daily 807 (6.8) 1,028 (7.9)
 Missing 101 (0.9) 108 (0.8)
Social situation        
 Living with others 7,918 (67) 8,597 (66)
 Living alone 3,858 (33) 4,246 (33)
 Nursing home. etc. 53 (0.4) 104 (0.8)
 Missing 44 (0.4) 42 (0.3)
Preoperative anemia b 2,907 (25) 3,159 (24)
 Missing 121 (1.0) 234 (1.8)
Use of walking aid 2,482 (21) 3,267 (25)
 Missing 232 (2.0) 0 (0.0)
Hypertension 5,809 (49) 5,699 (44)
 Missing 62 (0.5) 55 (0.4)
Hypercholesterolemia 4,779 (40) 4,656 (36)
 Missing 70 (0.6) 69 (0.5)
Pharmacologically treated    
 cardiac disease 1,691 (14) 1,740 (13)
    Missing 130 (1.1) 81 (0.6)
 pulmonary disease 1,042 (8.8) 1,109 (8.5)
    Missing 78 (0.7) 58 (0.4)
 psychiatric disorder 1,053 (8.9) 1,002 (7.7)
    Missing 91 (0.8) 61 (0.5)
Anticoagulant treatment c  745 (6.3) 777 (6.0)
 Missing 0 (0.0) 0 (0.0)
Prior cerebral stroke 744 (6.3) 752 (5.8)
 Missing 179 (1.5) 170 (1.3)
Diabetes        
 Insulin-dependent 300 (2.5) 202 (1.6)
 Non-insulin-dependent 1,222 (10) 899 (6.9)
 Missing 29 (0.2) 17 (0.1)
BMI = body mass index; THA = total hip arthroplasty; 
TKA = total knee arthroplasty.
a
 mean (SD); 
b Hb < 13 g/dL
c Vitamin K antagonists or new oral anticoagulants.
Figure 1. Flow of patients. DNPR = Danish National Patient Registry.
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was 6.3% (CI 2.2–17). 20 (0.08%, CI 0.05–0.12) patients died 
in their own home of unknown cause, with a median time to 
death of 64 (37–84) days. 
When analyzing risk factors for MI ≤ 30 days, age of > 85 
years (OR 6.9–8.3) and insulin-dependent diabetes mellitus 
(IDDM) (OR 3.6–5.0) were statistically significantly associ-
ated with increased risk of MI regardless of the type of regres-
sion model. Preoperative cardiac disease (OR 2.4–2.8) and 
hypercholesterolemia (OR 2.3–2.7) were also significantly 
associated with MI in both models including these covariates 
(Table 2). In contrast, sex, use of anticoagulants, and preoper-
ative anemia were not significantly associated with MI (Table 
2). When assessing risk factors for MI ≤ 90 days the results 
were much alike although the association with hypercholes-
terolemia was statistically not significant when adjusting for 
cardiac disease (p = 0.06), while male sex was significantly 
associated with MI ≤ 90 days (OR 2.3–2.5) in all 4 models 
(Table 3). 
In-hospital postoperative hemoglobin (Hb) levels were 
available in 28 of the 31 patients with MI ≤ 30 days. Of these, 
27 were anemic with a mean postoperative Hb of 9.9 (1.7) g/
dL, and with a mean postoperative Hb reduction of 3.6 g/dL 
(CI 2.8–4.3). 10 MI patients with postoperative anemia also 
had preoperative anemia. Perioperative anesthesia notes were 
available in 24 cases with MI ≤ 30 days; 18 procedures were 
performed under spinal anesthesia. 11 patients developed 
intraoperative hypotension < 90 mm/Hg, 6 during spinal anes-
thesia and 5 during general anesthesia. 9 of the intraoperative 
hypotensive patients required treatment with vasopressors, 5 
in the spinal anesthesia group and 4 in the general anesthesia 
group. No other cardiac events were recorded during the surgi-
cal procedure. 
Sensitivity analysis on the 19,793 patients with only 1 
procedure showed similar results as mentioned above in the 
entire cohort. Thus, in the 19,793 patients LOS was median 
2 (2–3) days, 7.6% (CI 7.2–7.9) had LOS ≥ 5 days and 7.9 
% (CI 7.5–8.3) had a readmission within 90 days. 26 patients 
(0.13%, CI 0.9–0.19) developed MI within 30 days and 41 
(0.21%, 0.16–0.29) within 90 days. Risk factors for MI ≤ 
30 days were age > 85 years OR 6.8 (CI 1.9–24, p = 0.003), 
IDDM OR 4.5 (CI 1.3–16, p = 0.02), hypercholesterolemia 
OR 2.4 (CI 1.0–5.7, p = 0.05) and cardiovascular disease OR 
2.3 (CI 1.0–5.2, p = 0.05). When analyzing the 5,069 patients 
with more than 1 procedure there was no difference. Median 
LOS was 2 (CI 2–3) days, 6.1% (CI 5.5–6.8%) had LOS ≥ 5 
Figure 2. Cumulated incidence of MI in 24,862 THA and TKA proce-
dures.
Table 2. Multivariable logistic regressions for preoperative risk factors for MI within 30 days of surgery
 Model 1 Model 2 Model 3 Model 4
Variable  OR (95% CI)       p-value OR (95% CI)  p-value OR (95% CI)       p-value OR (95% CI)  p-value
Age   0.009  0.003  0.002  0.006
 < 50 NA  NA  NA  NA 
 50–60 NA  NA  NA  NA 
 61–65 0.25 (0.03–2.1) 0.2 0.24 (0.03–2.0) 0.2 0.25 (0.03–2.1) 0.2 0.26 (0.03–2.2) 0.2
 66–70 1 Ref 1 Ref 1 Ref 1 Ref
 71–75 1.1 (0.35–3.3) 0.9 1.1 (0.36–3.4) 0.9 1.1 (0.36–3.4) 0.9 1.1 (0.35–3.3) 0.9
 76–80 1.3 (0.43–4.2) 0.6 1.5 (0.47–4.5) 0.5 1.4 (0.47–4.5) 0.5 1.3 (0.43–4.2) 0.6
 81–85 2.7 (0.85–8.4) 0.09 3.0 (0.94–8.3) 0.06 3.0 (0.95–9.3) 0.06 2.7 (0.85–8.5) 0.09
 > 85 6.9 (2.2–21.9) 0.001 7.9 (2.5–24.7) < 0.001 8.3 (2.6–26.3) < 0.001 7.4 (2.3–23.5) 0.001
Male sex 1.6 (0.79–3.3) 0.2 1.8 (0.86–3.6) 0.1 1.8 (0.87–3.6) 0.1 1.6 (0.79–3.33) 0.2
Diabetes  0.04  0.03  0.07  0.07
 Insulin-dependent  4.5 (1.3–15.3) 0.02 5.0 (1.5–16.7) 0.009 3.7 (1.1–12.6) 0.04 3.6 (1.1–12.4) 0.04
 Non-insulin-dependent  0.69 (0.16–2.9) 0.6 1.3 (0.58–2.8) 0.6 0.59 (0.14–2.5) 0.5 0.56 (0.13–2.4) 0.4
Cardiovascular disease 2.8 (1.3–5.8) 0.006 – – – – 2.4 (1.1–5.0) 0.02
Anemia a 1.2 (0.5–2.5) 0.7      
Hypercholesterolemia  – – – – 2.7 (1.3–5.9) 0.01 2.3 (1.1–5.1) 0.03
Anticoagulant treatment b – – 1.4 (0.50–4.2) 0.5 – – – –
Number of patients included in analysis differs from the total number of patients due to missing data. NA: not available due to lack of data. 
a Hb < 13 g/dL for both men and women.
b Vitamin K antagonists or new oral anticoagulants (NOAC).
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days,  90-day readmission rate was 6.6% (CI 6.0–7.4%) and 
30-day incidence of MI was 0.10% (CI 0.04–0.23%) and was 
similar compared with the entire cohort. When comparing the 
2 subgroups, 30-day MI incidence was similar (p = 0.7). How-
ever, patients with multiple procedures had a lower proportion 
of LOS ≥ 5 days (p < 0.001) and readmissions within 90 days 
(p = 0.003).
Discussion
In this prospective cohort study on 24,862 consecutive 
unselected primary elective fast-track THA and TKAs we 
found a 30-day MI incidence of 0.12% with increased risk for 
age > 85, IDDM, cardiovascular disease, and hypercholester-
olemia in multivariable analysis. Furthermore, perioperative 
anemia and intraoperative hypotension was frequent among 
patients with postoperative MI. 
Our MI incidence is lower than reported in studies on admin-
istrative databases reporting 30-day incidences of 0.25%–
0.9% (Singh et al. 2011, Lalmohamed et al. 2012, Belmont 
Jr et al. 2014, Pedersen et al. 2014, Thornqvist et al. 2014). 
A recent comparison of administrative data and the clinical 
NSQIP registry have shown a low specificity of ≈ 81% for 
both sources of data compared with chart review (Etzioni et al. 
2018), potentially underestimating the true incidence. None-
theless, we found an in-hospital incidence rate of only 0.05%, 
considerably lower than previous data from such administra-
tive and clinical registries with comparable cohorts but vari-
able follow-up (Pulido et al. 2008, Malviya et al. 2011, Ped-
ersen et al. 2014, Bemenderfer et al. 2017, Urban et al. 2017). 
Although, the numbers we found are comparable to previous 
fast-track THA and TKA studies (Malviya et al. 2011, Khan et 
al. 2014), previous studies lack detailed information on poten-
tial risk factors and events preceding MI. 
Median time to MI ≤ 30 days was 4 (2–8) days and 11 
(3–56) days for MI ≤ 90 days with increased cumulated inci-
dence within the first 3 weeks. This is in concordance with 
previous data from the few THA- and TKA-specific studies, 
which report increased risk of MI within the first 2 weeks and 
up to 6 weeks for THA (Lalmohamed et al. 2012, Belmont Jr 
et al. 2014). 
When evaluating preoperative risk factors for MI ≤ 90 days, 
age > 85 years was found to be the most important risk factor 
for MI with OR of about 6. That increasing age is a risk factor 
for MI has been demonstrated in several studies (Belmont Jr 
et al. 2014, Menendez et al. 2015, Urban et al. 2017); how-
ever, we were unable to demonstrate any significant associa-
tion between age and MI until age > 85 years. That IDDM, 
cardiovascular disease, and hypercholesterolemia were found 
to be associated with MI in our study is unsurprising as these 
are well-known risk factors (Mantilla et al. 2011, Belmont Jr 
et al. 2014, Menendez et al. 2015). However, that male sex 
was clearly associated with 90- but not 30-day MI has to our 
knowledge not been shown previously. A previous investiga-
tion on early thromboembolic events including some of the 
same patients as our study suggested postoperative anemia as 
a possible pathogenic mechanism (Jørgensen et al. 2016a). 
Preoperative anemia is well known to dispose to postopera-
tive anemia and blood transfusions (Goodnough et al. 2011), 
including in fast-track THA and TKA (Jans et al. 2018). In 
our study, preoperative anemia was not associated with MI. 
However, 12 of the 48 patients with MI had preoperative and 
27 had postoperative anemia. Although conflicting results 
on anemia as a risk factor for postoperative MI have been 
discussed previously (Mantilla et al. 2011, Menendez et al. 
Table 3. Multivariable logistic regressions for preoperative risk factors for MI within 90 days of surgery
 Model 1 Model 2 Model 3 Model 4
Variable  OR (95% CI)       p-value OR (95% CI)  p-value OR (95% CI)       p-value OR (95% CI)  p-value
Age  < 0.001  < 0.001  < 0.001  < 0.001
 < 50 NA  NA  NA  NA 
 50–60 0.13 (0.02–1.0) 0.05 0.12 (0.02–0.90) 0.04 0.13 (0.02–1.0) 0.05 0.14 (0.02–1.1) 0.06
 61–65 0.14 (0.02–1.1) 0.06 0.13 (0.02–1.0) 0.05 0.14 (0.02–1.0) 0.06 0.14 (0.02–1.1) 0.06
 66–70 1 Ref 1 Ref 1 Ref 1 Ref
 71–75 0.78 (0.31–2.0) 0.6 0.81 (0.32–2.0) 0.6 0.81 (0.32–2.0) 0.6 0.78 (0.31–1.9) 0.6
 76–80 1.2 (0.51–2.9) 0.7 1.3 (0.56–3.14) 0.5 1.3 (0.57–3.2) 0.5 1.2 (0.52–2.9) 0.6
 81–85 2.2 (0.89–5.4) 0.09 2.5 (1.0–6.0) 0.05 2.5 (1.0–6.2) 0.04 2.3 (0.9–5.5) 0.07
 > 85 5.0 (1.9–12.9) 0.001 5.9 (2.4–15.1) < 0.001 6.3 (2.5–16.0) < 0.001 5.5 (2.2–12.1) < 0.001
Male sex 2.3 (1.3–4.3) 0.005 2.5 (1.4–4.5) 0.002 2.5 (1.4–4.5) 0.002 2.3 (1.3–4.1) 0.006
Diabetes  0.003  0.002  0.006  0.006
 Insulin-dependent  4.4 (1.7–11.5) 0.002 5.0 (1.9–12.9) 0.001 3.9 (1.5–10.2) 0.006 3.9 (1.5–10.1) 0.006
 Non-Insulin-dependent  0.42 (0.10–1.7) 0.2 0.47 (0.11–1.9) 0.3 0.38 (0.09–1.6) 0.2 0.36 (0.09–1.5) 0.2
Cardiovascular disease 3.0 (1.7–5.4) < 0.001 – – – – 2.7 (1.4–4.9) 0.001
Anemia a 1.2 (0.62–2.2) 0.6      
Hypercholesterolemia  – – – – 2.2 (1.2–4.0) 0.01 1.8 (0.99–3.4) 0.06
Anticoagulant treatment b – – 1.7 (0.73–3.7) 0.2 – – – –
For footnotes, see Table 2.
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2015), anemia can and should be prevented both pre- and post-
operatively (Goodnough et al. 2013, Belmont Jr et al. 2014, 
Pujol-Nicolas et al. 2017), and increased focus on blood man-
agement remains a potential “low hanging fruit” for further 
improvement. 
We also identified 11 cases of intraoperative hypotension of 
which 9 cases were treated with vasopressors. This occurred 
in 5 of 6 MI patients having general anesthesia in contrast to 
6 of 18 patients having spinal anesthesia. Several studies from 
unspecific non-cardiac surgery have shown an association 
between intraoperative hypotension and risk of MI and mor-
tality (Walsh et al. 2013, Roshanov et al. 2017, Sessler et al. 
2017). Thus, an increased focus on avoiding a supply–demand 
mismatch during surgery may possibly further decrease the risk 
of MI. This hypothesis is also backed by a positive effect of an 
individualized blood pressure management strategy lowering 
postoperative organ dysfunction (Futier et al. 2017), although 
not specifically addressing MI. In addition, a recent study on 
etiology of MI after non-cardiac surgery found about 75% of 
MIs to be “demand” ischemia (type 2 myocardial infarctions) 
(Garcia et al. 2014). However, we do not know the incidence of 
intraoperative hypotension in patients who did not develop MI 
and, thus, further research on intraoperative hypotension and 
postoperative MI in THA and TKA is needed.
Our study has some methodological limitations. We only 
obtained health records from patients with LOS ≥ 5 days, 
readmission, and/or death within 90 days. Thus, a case of MI 
during primary admission with total LOS < 5 days and with-
out a diagnostic code of MI would be missed. However, that 
a patient with MI would be discharged within 4 days of sur-
gery without a diagnostic code and no postoperative prescrip-
tions of anticoagulants is unlikely. Although the LCDB aims 
at including all patients, 3% of the eligible population from 
the DNPR was missing in the LCDB (see Figure 1). However, 
we have previously shown similar postoperative outcomes in 
these patients (Jørgensen et al. 2013). Data on readmissions 
were obtained from the DNPR, which has shown varying reli-
ability with regards to specific diagnostic codes (Vest-Hansen 
et al. 2013, Egholm et al. 2016) but > 99% overall reliability 
with regards to somatic admission (Schmidt et al. 2015). Con-
sequently, we obtained discharge summaries on all patients 
with LOS ≥ 5 and medical records including results from 
blood samples and intraoperative anesthesia records in case 
of MI to ensure best available information on incidence and 
pathophysiological mechanisms (Etzioni et al. 2018). 
The declining autopsy rate in Denmark limits the availabil-
ity of specific cause of death as seen in our study by 20 deaths 
of unknown causes. Consequently, although we obtained all 
healthcare records of patients dying ≤ 90 days of surgery to 
establish potential relation to surgery, we may underestimate 
the true MI incidence. Nonetheless, most deaths of unknown 
reason occurred > 30 days postoperatively, and even if all 20 
deaths were due MI, the 90-day MI rate would remain < 0.3%. 
The lack of information on postoperative anemia and intraop-
erative hypotension in patients not developing MI precluded 
relevant statistical analyses. Likewise, Hb values at readmis-
sion were not consistently available, thus precluding conclu-
sions on possible effects of post-discharge anemia and MI. 
Furthermore, our study design also impedes comparison on 
risk of MI with a non-surgical group as no matched control 
group was made. 
Finally, about 10% of the patients had a second procedure 
during the study period, which may limit external validity of 
our results (Bryant et al. 2006). However, the incidence of and 
risk factors for MI among the patients with only 1 procedure 
or those with multiple primary arthroplasties was not different 
from the entire cohort. Additionally, leaving out patients with 
multiple primary arthroplasties may also introduce additional 
bias to postoperative outcomes (Ravi et al. 2013). Nonetheless, 
the inclusion of consecutive “real-life” patients from 8 differ-
ent centers throughout Denmark without any selection bias 
increases the generalizability within fast-track THA and TKA. 
In summary, the incidence of MI ≤ 30 days after fast-track 
THA and TKA was only 0.12%, increasing to 0.19% at 90 
day. Age > 85 years, IDDM, hypercholesterolemia, and car-
diovascular disease were associated with MI ≤ 30 days. The 
roles of perioperative anemia and intraoperative hypotension 
as potential modifiable risk factors of developing MI remain 
areas for further research.  
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